Hainan Poly Pharm Co (SZSE:300630) 3-Year EBITDA Growth Rate : 12.60% (As of Sep. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Hainan Poly Pharm Co 3-Year EBITDA Growth Rate?

Hainan Poly Pharm Co's EBITDA per Share for the three months ended in Sep. 2023 was ¥0.30.

During the past 12 months, Hainan Poly Pharm Co's average EBITDA Per Share Growth Rate was -44.20% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 12.60% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 32.30% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 34.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 11 years, the highest 3-Year average EBITDA Per Share Growth Rate of Hainan Poly Pharm Co was 53.70% per year. The lowest was 12.60% per year. And the median was 35.55% per year.

Competitive Comparison of Hainan Poly Pharm Co's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Hainan Poly Pharm Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hainan Poly Pharm Co's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hainan Poly Pharm Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Hainan Poly Pharm Co's 3-Year EBITDA Growth Rate falls into.

Hainan Poly Pharm Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Hainan Poly Pharm Co (SZSE:300630) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Hainan Poly Pharm Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Hainan Poly Pharm Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Hainan Poly Pharm Co (SZSE:300630) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hainan Poly Pharm Co Ltd (SZSE:300630) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

N/A

Address

No.1509 Binsheng Road, 10th Floor, Zhejiang Province, Hangzhou, CHN, 310051

Website

http://www.hnpoly.com

Hainan Poly Pharm Co Ltd is a pharmaceutical manufacturer in China. It manufactures injections, oral solid formulations, dry suspension, and other active pharmaceutical ingredients. The products offered by the company include Azithromycin for Injection, Ganciclovir Sodium for Injection. Octreotide Acetate Injection, Trimebutine Maleate tablets, Desloratadine, Trimebutine Maleate, and GANCICLOVIR among others.

Hainan Poly Pharm Co (SZSE:300630) Headlines

No Headlines